Cardiovascular risk prediction in hemodialysis patients using the triglyceride-glucose index: a multicenter

Yu Ho Lee1, Seok Hui Kang2, Dae Kyu Kim3

  • 1Division of Nephrology, Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea.

PubMed

Insights

The Triglyceride-glucose (TyG) index indicates higher cardiovascular risk in hemodialysis patients. This index may help identify individuals needing closer monitoring for adverse cardiac events.

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Syndrome

Background:

  • Insulin resistance is a growing concern in hemodialysis patients.
  • The Triglyceride-glucose (TyG) index is a novel marker for insulin resistance.
  • The clinical utility of the TyG index in hemodialysis patients is currently unknown.

Purpose of the Study:

  • To investigate the association between the TyG index and cardiovascular (CV) disease risk in patients undergoing maintenance hemodialysis.
  • To explore the relationship between the TyG index and vascular pathology markers.
  • To determine if the TyG index can predict adverse CV outcomes in this population.

Main Methods:

  • A prospective study enrolled 759 hemodialysis patients.
  • Participants were categorized into tertiles based on baseline TyG index.
  • Echocardiographic parameters, vascular calcification scores, and plasma biomarkers were assessed.

Main Results:

  • The TyG index positively correlated with endostatin and vascular adhesion protein-1.
  • No correlation was found between the TyG index and vascular calcification or echocardiographic parameters.
  • Patients in the highest TyG index tertile had significantly higher cumulative rates of CV and cardiac events.

Conclusions:

  • The TyG index is linked to vascular pathology markers in hemodialysis patients.
  • Elevated TyG index is associated with an increased risk of adverse CV outcomes.
  • The TyG index may serve as a valuable tool for identifying high-CV risk individuals in hemodialysis settings.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
115
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
40
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
247
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
257